Obesity and age as dominant correlates of low testosterone in men irrespective of diabetes status

Summary Although men with type 2 diabetes (T2D) frequently have lowered testosterone levels, it is not well established whether this is ascribable to the diabetic state per se, or because of other factors, such as obesity. Our objective was to determine the prevalence and correlates of low testoster...

Full description

Saved in:
Bibliographic Details
Published in:Andrology (Oxford) Vol. 1; no. 6; pp. 906 - 912
Main Authors: Ng Tang Fui, M., Hoermann, R., Cheung, A. S., Gianatti, E. J., Zajac, J. D., Grossmann, M.
Format: Journal Article
Language:English
Published: Schaumburg, IL American Society of Andrology 01-11-2013
Wiley Subscription Services, Inc
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Summary Although men with type 2 diabetes (T2D) frequently have lowered testosterone levels, it is not well established whether this is ascribable to the diabetic state per se, or because of other factors, such as obesity. Our objective was to determine the prevalence and correlates of low testosterone in middle‐aged men with diabetes. We conducted a cross‐sectional study in 240 men including 80 men with type 1 diabetes (T1D), 80 men with T2D and 80 men without diabetes. Prevalence of a total testosterone ≤8 nmol/L was low, occurring in none of the men with T1D, 6.2% of men with T2D and 2.5% of men without diabetes. Men with T1D had higher testosterone levels compared with men without diabetes (p < 0.001), even after adjustment for body mass index (BMI) and age (p < 0.02). While men with T2D had lower testosterone compared with controls (p = 0.03), this was no longer significant when BMI and age were taken into account (p = 0.16). In the entire cohort, TT remained inversely associated with BMI independent of age, sex hormone‐binding globulin and diabetic status (p = 0.01), whereas calculated free testosterone (cFT) was independently and inversely associated with age (p < 0.001), but not with BMI (p = 0.47). These results suggest that marked reductions in circulating testosterone are uncommon in middle‐aged men with diabetes. Increasing BMI and age are dominant drivers of lowered total and cFT, respectively, independent of the presence or absence of diabetes.
AbstractList Summary Although men with type 2 diabetes (T2D) frequently have lowered testosterone levels, it is not well established whether this is ascribable to the diabetic state per se, or because of other factors, such as obesity. Our objective was to determine the prevalence and correlates of low testosterone in middle-aged men with diabetes. We conducted a cross-sectional study in 240 men including 80 men with type 1 diabetes (T1D), 80 men with T2D and 80 men without diabetes. Prevalence of a total testosterone ≤8 nmol/L was low, occurring in none of the men with T1D, 6.2% of men with T2D and 2.5% of men without diabetes. Men with T1D had higher testosterone levels compared with men without diabetes (p < 0.001), even after adjustment for body mass index (BMI) and age (p < 0.02). While men with T2D had lower testosterone compared with controls (p = 0.03), this was no longer significant when BMI and age were taken into account (p = 0.16). In the entire cohort, TT remained inversely associated with BMI independent of age, sex hormone-binding globulin and diabetic status (p = 0.01), whereas calculated free testosterone (cFT) was independently and inversely associated with age (p < 0.001), but not with BMI (p = 0.47). These results suggest that marked reductions in circulating testosterone are uncommon in middle-aged men with diabetes. Increasing BMI and age are dominant drivers of lowered total and cFT, respectively, independent of the presence or absence of diabetes.
Summary Although men with type 2 diabetes (T2D) frequently have lowered testosterone levels, it is not well established whether this is ascribable to the diabetic state per se, or because of other factors, such as obesity. Our objective was to determine the prevalence and correlates of low testosterone in middle‐aged men with diabetes. We conducted a cross‐sectional study in 240 men including 80 men with type 1 diabetes (T1D), 80 men with T2D and 80 men without diabetes. Prevalence of a total testosterone ≤8 nmol/L was low, occurring in none of the men with T1D, 6.2% of men with T2D and 2.5% of men without diabetes. Men with T1D had higher testosterone levels compared with men without diabetes (p < 0.001), even after adjustment for body mass index (BMI) and age (p < 0.02). While men with T2D had lower testosterone compared with controls (p = 0.03), this was no longer significant when BMI and age were taken into account (p = 0.16). In the entire cohort, TT remained inversely associated with BMI independent of age, sex hormone‐binding globulin and diabetic status (p = 0.01), whereas calculated free testosterone (cFT) was independently and inversely associated with age (p < 0.001), but not with BMI (p = 0.47). These results suggest that marked reductions in circulating testosterone are uncommon in middle‐aged men with diabetes. Increasing BMI and age are dominant drivers of lowered total and cFT, respectively, independent of the presence or absence of diabetes.
Although men with type 2 diabetes (T2D) frequently have lowered testosterone levels, it is not well established whether this is ascribable to the diabetic state per se, or because of other factors, such as obesity. Our objective was to determine the prevalence and correlates of low testosterone in middle-aged men with diabetes. We conducted a cross-sectional study in 240 men including 80 men with type 1 diabetes (T1D), 80 men with T2D and 80 men without diabetes. Prevalence of a total testosterone ≤8 nmol/L was low, occurring in none of the men with T1D, 6.2% of men with T2D and 2.5% of men without diabetes. Men with T1D had higher testosterone levels compared with men without diabetes (p < 0.001), even after adjustment for body mass index (BMI) and age (p < 0.02). While men with T2D had lower testosterone compared with controls (p = 0.03), this was no longer significant when BMI and age were taken into account (p = 0.16). In the entire cohort, TT remained inversely associated with BMI independent of age, sex hormone-binding globulin and diabetic status (p = 0.01), whereas calculated free testosterone (cFT) was independently and inversely associated with age (p < 0.001), but not with BMI (p = 0.47). These results suggest that marked reductions in circulating testosterone are uncommon in middle-aged men with diabetes. Increasing BMI and age are dominant drivers of lowered total and cFT, respectively, independent of the presence or absence of diabetes.
Although men with type 2 diabetes (T2D) frequently have lowered testosterone levels, it is not well established whether this is ascribable to the diabetic state per se, or because of other factors, such as obesity. Our objective was to determine the prevalence and correlates of low testosterone in middle-aged men with diabetes. We conducted a cross-sectional study in 240 men including 80 men with type 1 diabetes (T1D), 80 men with T2D and 80 men without diabetes. Prevalence of a total testosterone ≤8 nmol/L was low, occurring in none of the men with T1D, 6.2% of men with T2D and 2.5% of men without diabetes. Men with T1D had higher testosterone levels compared with men without diabetes (p &lt; 0.001), even after adjustment for body mass index (BMI) and age (p &lt; 0.02). While men with T2D had lower testosterone compared with controls (p = 0.03), this was no longer significant when BMI and age were taken into account (p = 0.16). In the entire cohort, TT remained inversely associated with BMI independent of age, sex hormone-binding globulin and diabetic status (p = 0.01), whereas calculated free testosterone (cFT) was independently and inversely associated with age (p &lt; 0.001), but not with BMI (p = 0.47). These results suggest that marked reductions in circulating testosterone are uncommon in middle-aged men with diabetes. Increasing BMI and age are dominant drivers of lowered total and cFT, respectively, independent of the presence or absence of diabetes.
Author Gianatti, E. J.
Ng Tang Fui, M.
Zajac, J. D.
Cheung, A. S.
Grossmann, M.
Hoermann, R.
Author_xml – sequence: 1
  givenname: M.
  surname: Ng Tang Fui
  fullname: Ng Tang Fui, M.
  organization: Austin Health
– sequence: 2
  givenname: R.
  surname: Hoermann
  fullname: Hoermann, R.
  organization: The University of Melbourne
– sequence: 3
  givenname: A. S.
  surname: Cheung
  fullname: Cheung, A. S.
  organization: Austin Health
– sequence: 4
  givenname: E. J.
  surname: Gianatti
  fullname: Gianatti, E. J.
  organization: Austin Health
– sequence: 5
  givenname: J. D.
  surname: Zajac
  fullname: Zajac, J. D.
  organization: Austin Health
– sequence: 6
  givenname: M.
  surname: Grossmann
  fullname: Grossmann, M.
  organization: Austin Health
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27844689$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/24115523$$D View this record in MEDLINE/PubMed
BookMark eNqNkU9r3DAQxUVJaNI0X6EISqGX3UqybFmHHkL6F0ICoT2LsTQuWmxpK9lN9ttXzm630FMHgR7oN6PHmxfkJMSAhFDO1rzUu81aMKlWQgtVFK_WjHEh14_PyPnx4eSouT4jlzlvWKl2OeI5OROS87oW1TmBuw6zn3YUgqPwAylk6uLoA4SJ2pgSDjBhprGnQ3ygRU4xT5iKJeoDHTFQX6C8RTv5X7hwzkOHS0-eYJrzS3Law5Dx8nBfkO-fPn67_rK6ufv89frqZmWlUnLlbAPCaWe1033FrNJaNa5VVkDNlINK9J2tK2vrrsa-cn0HiNAWFLDTdVNdkLf7udsUf87Fpxl9tjgMEDDO2XApFWdtI3lBX_-DbuKcQnFneFO1QjCtFqrdUzbFnBP2Zpv8CGlnODPLJszGLCGbJXCzbMI8bcI8ltZXhw_mbkR3bPyTewHeHADIFoY-QbA-_-VUK2XT6sK933MPfsDdfxswV7cf7ouqfgMzc6ax
CitedBy_id crossref_primary_10_1016_j_jse_2019_08_008
crossref_primary_10_1016_j_jcjd_2017_10_035
crossref_primary_10_1177_15579883241235062
crossref_primary_10_4081_aiua_2022_4_464
crossref_primary_10_1080_13685538_2018_1557139
crossref_primary_10_1111_jdi_13903
crossref_primary_10_1093_ajcn_nqab253
crossref_primary_10_3390_ijms231911952
crossref_primary_10_1097_MED_0000000000000057
crossref_primary_10_1530_JOE_13_0393
crossref_primary_10_1111_and_12485
crossref_primary_10_1111_andr_12705
crossref_primary_10_1111_cen_12768
crossref_primary_10_1111_and_13035
crossref_primary_10_1007_s11596_015_1469_3
crossref_primary_10_1111_cen_13723
crossref_primary_10_3109_13685538_2015_1034687
crossref_primary_10_1210_jc_2014_1317
crossref_primary_10_1155_2018_4926789
crossref_primary_10_1111_and_12419
crossref_primary_10_1111_andr_13544
crossref_primary_10_1530_ERC_17_0466
crossref_primary_10_1007_s11930_014_0030_x
crossref_primary_10_1007_s00345_018_2256_0
Cites_doi 10.2164/jandrol.108.007005
10.1210/jc.2011-1137
10.1016/j.ecl.2011.05.004
10.2337/dc07-2169
10.1111/j.1365-2265.2010.03942.x
10.1210/jc.2007-1972
10.1210/jc.2011-2513
10.1210/jc.2006-1859
10.2337/dc08-0851
10.1111/cen.12086
10.1056/NEJMoa0804381
10.2337/dc06-1426
10.1001/jama.295.11.1288
10.2337/diacare.26.6.1812
10.1038/ncpendmet0120
10.1111/j.1365-2265.2012.04432.x
10.1210/jc.2004-0804
10.1210/jc.2011-0118
10.2174/157339912799424573
10.1530/EJE-12-0890
10.1210/jc.2005-0962
10.1097/MED.0b013e32833919cf
10.5694/j.1326-5377.2011.tb02979.x
10.1016/j.steroids.2010.01.011
10.1530/EJE-12-0525
10.1097/MED.0b013e3283398ee2
10.1210/jc.2009-2354
10.1111/j.1365-2265.2011.04196.x
10.1210/jc.2007-2177
10.5694/j.1326-5377.2004.tb06060.x
10.1111/j.1365-2605.2010.01117.x
10.1038/ncpendmet1050
10.1210/jc.84.10.3666
ContentType Journal Article
Copyright 2013 American Society of Andrology and European Academy of Andrology
2014 INIST-CNRS
2013 American Society of Andrology and European Academy of Andrology.
Andrology©2013 American Society of Andrology and European Academy of Andrology
Copyright_xml – notice: 2013 American Society of Andrology and European Academy of Andrology
– notice: 2014 INIST-CNRS
– notice: 2013 American Society of Andrology and European Academy of Andrology.
– notice: Andrology©2013 American Society of Andrology and European Academy of Andrology
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
K9.
7X8
DOI 10.1111/j.2047-2927.2013.00124.x
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest Health & Medical Complete (Alumni)

MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 2047-2927
EndPage 912
ExternalDocumentID 3531678371
10_1111_j_2047_2927_2013_00124_x
24115523
27844689
ANDR124
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Victoria
GeographicLocations_xml – name: Victoria
GrantInformation_xml – fundername: National Health and Medical Research Council of Australia
  funderid: 105305; 1024139
GroupedDBID .Y3
05W
0R~
1OC
24P
31~
33P
3SF
50Y
50Z
52U
52V
53G
8-1
8-4
8-5
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCUV
ABDBF
ABJNI
ABLJU
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
C45
D-7
D-F
DCZOG
DIK
DPXWK
DRFUL
DRMAN
DRSTM
EAD
EAP
EAS
EBC
EBD
EBS
EBX
EHN
EJD
EMB
EMK
EMOBN
EPL
EPT
ESX
FUBAC
G-S
G.N
GODZA
H.X
HGLYW
HZ~
KBYEO
LATKE
LEEKS
LH4
LITHE
LOXES
LUTES
LW6
LYRES
MEWTI
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
NF~
O66
O9-
OVD
P0-
P2W
PQQKQ
Q.N
QB0
Q~Q
R.K
ROL
SUPJJ
SV3
TEORI
TUS
WBKPD
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WVDHM
WXSBR
ZZTAW
~IA
~WT
AAPBV
AAVGM
ABHUG
ABPTK
ACXME
ADAWD
ADDAD
AFVGU
AGJLS
IQODW
PQEST
WRC
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
K9.
7X8
ID FETCH-LOGICAL-c4774-dc6a2d9dc9d9f30c79976d87c2a507da32fbc53cc5b5ef3dfbaeea8f30aeb9563
IEDL.DBID 33P
ISSN 2047-2919
IngestDate Fri Aug 16 09:49:38 EDT 2024
Thu Oct 10 23:00:38 EDT 2024
Fri Aug 23 09:37:31 EDT 2024
Sat Sep 28 07:52:38 EDT 2024
Fri Nov 25 01:07:59 EST 2022
Sat Aug 24 00:52:20 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Endocrinopathy
Human
Obesity
Senescence
Androgen
Diabetes mellitus
Ageing
Nutrition disorder
Male
Testosterone
Testicular hormone
Sex steroid hormone
diabetes
Nutritional status
ageing
testosterone
obesity
Language English
License CC BY 4.0
2013 American Society of Andrology and European Academy of Andrology.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4774-dc6a2d9dc9d9f30c79976d87c2a507da32fbc53cc5b5ef3dfbaeea8f30aeb9563
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.2047-2927.2013.00124.x
PMID 24115523
PQID 1638220971
PQPubID 2034368
PageCount 7
ParticipantIDs proquest_miscellaneous_1447108641
proquest_journals_1638220971
crossref_primary_10_1111_j_2047_2927_2013_00124_x
pubmed_primary_24115523
pascalfrancis_primary_27844689
wiley_primary_10_1111_j_2047_2927_2013_00124_x_ANDR124
PublicationCentury 2000
PublicationDate November 2013
PublicationDateYYYYMMDD 2013-11-01
PublicationDate_xml – month: 11
  year: 2013
  text: November 2013
PublicationDecade 2010
PublicationPlace Schaumburg, IL
PublicationPlace_xml – name: Schaumburg, IL
– name: England
– name: Hoboken
PublicationTitle Andrology (Oxford)
PublicationTitleAlternate Andrology
PublicationYear 2013
Publisher American Society of Andrology
Wiley Subscription Services, Inc
Publisher_xml – name: American Society of Andrology
– name: Wiley Subscription Services, Inc
References 2010; 34
2011b; 40
2010; 75
2012; 167
2004; 180
2010; 17
2005; 90
2004; 89
2006; 295
2011; 96
2011; 74
2013; 168
2007; 92
1999; 84
2006; 2
2008; 31
2007; 30
2008; 93
2012; 77
2012; 76
2012; 97
2009; 30
2011a; 194
2013; 78
2003; 26
2011c; 96
2009; 361
2009; 5
2010; 95
2012; 8
Hamilton (10.1111/j.2047-2927.2013.00124.x-BIB0019|andr124-cit-0019) 2011; 74
Maric (10.1111/j.2047-2927.2013.00124.x-BIB0024|andr124-cit-0024) 2010; 75
Grossmann (10.1111/j.2047-2927.2013.00124.x-BIB0016|andr124-cit-0016) 2008; 93
Travison (10.1111/j.2047-2927.2013.00124.x-BIB0029|andr124-cit-0029) 2007; 92
Wallace (10.1111/j.2047-2927.2013.00124.x-BIB0031|andr124-cit-0031) 2013; 78
Allan (10.1111/j.2047-2927.2013.00124.x-BIB0001|andr124-cit-0001) 2010; 17
Araujo (10.1111/j.2047-2927.2013.00124.x-BIB0002|andr124-cit-0002) 2011; 96
Bhasin (10.1111/j.2047-2927.2013.00124.x-BIB0003|andr124-cit-0003) 2006; 2
Grossmann (10.1111/j.2047-2927.2013.00124.x-BIB0017|andr124-cit-0017) 2010; 17
Saad (10.1111/j.2047-2927.2013.00124.x-BIB0025|andr124-cit-0025) 2012; 8
Bhasin (10.1111/j.2047-2927.2013.00124.x-BIB0004|andr124-cit-0004) 2010; 95
Sartorius (10.1111/j.2047-2927.2013.00124.x-BIB0026|andr124-cit-0026) 2012; 77
Camacho (10.1111/j.2047-2927.2013.00124.x-BIB0006|andr124-cit-0006) 2013; 168
Danielson (10.1111/j.2047-2927.2013.00124.x-BIB0010|andr124-cit-0010) 2008; 31
Heufelder (10.1111/j.2047-2927.2013.00124.x-BIB0021|andr124-cit-0021) 2009; 30
Yeap (10.1111/j.2047-2927.2013.00124.x-BIB0033|andr124-cit-0033) 2009; 5
Grossmann (10.1111/j.2047-2927.2013.00124.x-BIB0014|andr124-cit-0014) 2011c; 96
Hoyos (10.1111/j.2047-2927.2013.00124.x-BIB0022|andr124-cit-0022) 2012; 167
Sikaris (10.1111/j.2047-2927.2013.00124.x-BIB0027|andr124-cit-0027) 2005; 90
Dam (10.1111/j.2047-2927.2013.00124.x-BIB0009|andr124-cit-0009) 2003; 26
Corona (10.1111/j.2047-2927.2013.00124.x-BIB0008|andr124-cit-0008) 2010; 34
Vermeulen (10.1111/j.2047-2927.2013.00124.x-BIB0030|andr124-cit-0030) 1999; 84
Ding (10.1111/j.2047-2927.2013.00124.x-BIB0013|andr124-cit-0013) 2009; 361
Ding (10.1111/j.2047-2927.2013.00124.x-BIB0012|andr124-cit-0012) 2006; 295
Grossmann (10.1111/j.2047-2927.2013.00124.x-BIB0018|andr124-cit-0018) 2011a; 194
Tajar (10.1111/j.2047-2927.2013.00124.x-BIB0028|andr124-cit-0028) 2012; 97
Chandel (10.1111/j.2047-2927.2013.00124.x-BIB0007|andr124-cit-0007) 2008; 31
Kapoor (10.1111/j.2047-2927.2013.00124.x-BIB0023|andr124-cit-0023) 2007; 30
Biswas (10.1111/j.2047-2927.2013.00124.x-BIB0005|andr124-cit-0005) 2012; 76
Dhindsa (10.1111/j.2047-2927.2013.00124.x-BIB0011|andr124-cit-0011) 2004; 89
Grossmann (10.1111/j.2047-2927.2013.00124.x-BIB0015|andr124-cit-0015) 2011b; 40
Wu (10.1111/j.2047-2927.2013.00124.x-BIB0032|andr124-cit-0032) 2008; 93
Handelsman (10.1111/j.2047-2927.2013.00124.x-BIB0020|andr124-cit-0020) 2004; 180
References_xml – volume: 34
  start-page: 528
  year: 2010
  end-page: 540
  article-title: Type 2 diabetes mellitus and testosterone: a meta‐analysis study
  publication-title: Int J Androl
– volume: 93
  start-page: 2737
  year: 2008
  end-page: 2745
  article-title: Hypothalamic‐pituitary‐testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study
  publication-title: J Clin Endocrinol Metab
– volume: 17
  start-page: 247
  year: 2010
  end-page: 256
  article-title: Testosterone and type 2 diabetes
  publication-title: Curr Opin Endocrinol Diabetes Obes
– volume: 17
  start-page: 224
  year: 2010
  end-page: 232
  article-title: Androgens and obesity
  publication-title: Curr Opin Endocrinol Diabetes Obes
– volume: 96
  start-page: 3007
  year: 2011
  end-page: 3019
  article-title: Clinical review: endogenous testosterone and mortality in men: a systematic review and meta‐analysis
  publication-title: J Clin Endocrinol Metab
– volume: 5
  start-page: 113
  year: 2009
  end-page: 121
  article-title: Testosterone and ill‐health in aging men
  publication-title: Nat Clin Pract Endocrinol Metab
– volume: 2
  start-page: 146
  year: 2006
  end-page: 159
  article-title: Drug insight: testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging
  publication-title: Nat Clin Pract Endocrinol Metab
– volume: 95
  start-page: 2536
  year: 2010
  end-page: 2559
  article-title: Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
  publication-title: J Clin Endocrinol Metab
– volume: 75
  start-page: 772
  year: 2010
  end-page: 778
  article-title: Association between testosterone, estradiol and sex hormone binding globulin levels in men with type 1 diabetes with nephropathy
  publication-title: Steroids
– volume: 8
  start-page: 131
  year: 2012
  end-page: 143
  article-title: Testosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review
  publication-title: Curr Diabetes Rev
– volume: 78
  start-page: 321
  year: 2013
  end-page: 329
  article-title: Sex hormone binding globulin and insulin resistance
  publication-title: Clin Endocrinol (Oxf)
– volume: 26
  start-page: 1812
  year: 2003
  end-page: 1818
  article-title: Steroids in adult men with type 1 diabetes: a tendency to hypogonadism
  publication-title: Diabetes Care
– volume: 194
  start-page: 301
  year: 2011a
  end-page: 306
  article-title: Bone and metabolic health in patients with non‐metastatic prostate cancer who are receiving androgen deprivation therapy
  publication-title: Med J Aust
– volume: 295
  start-page: 1288
  year: 2006
  end-page: 1299
  article-title: Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta‐analysis
  publication-title: JAMA
– volume: 30
  start-page: 911
  year: 2007
  end-page: 917
  article-title: Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity
  publication-title: Diabetes Care
– volume: 74
  start-page: 377
  year: 2011
  end-page: 383
  article-title: Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy
  publication-title: Clin Endocrinol (Oxf)
– volume: 97
  start-page: 1508
  year: 2012
  end-page: 1516
  article-title: Characteristics of androgen deficiency in late‐onset hypogonadism: results from the European Male Aging Study (EMAS)
  publication-title: J Clin Endocrinol Metab
– volume: 89
  start-page: 5462
  year: 2004
  end-page: 5468
  article-title: Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes
  publication-title: J Clin Endocrinol Metab
– volume: 361
  start-page: 1152
  year: 2009
  end-page: 1163
  article-title: Sex hormone‐binding globulin and risk of type 2 diabetes in women and men
  publication-title: N Engl J Med
– volume: 93
  start-page: 1834
  year: 2008
  end-page: 1840
  article-title: Low testosterone levels are common and associated with insulin resistance in men with diabetes
  publication-title: J Clin Endocrinol Metab
– volume: 92
  start-page: 549
  year: 2007
  end-page: 555
  article-title: The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men
  publication-title: J Clin Endocrinol Metab
– volume: 96
  start-page: 2341
  year: 2011c
  end-page: 2353
  article-title: Low testosterone in men with type 2 diabetes: significance and treatment
  publication-title: J Clin Endocrinol Metab
– volume: 84
  start-page: 3666
  year: 1999
  end-page: 3672
  article-title: A critical evaluation of simple methods for the estimation of free testosterone in serum
  publication-title: J Clin Endocrinol Metab
– volume: 167
  start-page: 531
  year: 2012
  end-page: 541
  article-title: Body compositional and cardiometabolic effects of testosterone therapy in obese men with severe obstructive sleep apnoea: a randomised placebo‐controlled trial
  publication-title: Eur J Endocrinol
– volume: 40
  start-page: 655
  year: 2011b
  end-page: 671
  article-title: Management of side effects of androgen deprivation therapy
  publication-title: Endocrinol Metab Clin North Am
– volume: 168
  start-page: 445
  year: 2013
  end-page: 455
  article-title: Age‐associated changes in hypothalamic‐pituitary‐testicular function in middle‐aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study
  publication-title: Eur J Endocrinol
– volume: 90
  start-page: 5928
  year: 2005
  end-page: 5936
  article-title: Reproductive hormone reference intervals for healthy fertile young men: evaluation of automated platform assays
  publication-title: J Clin Endocrinol Metab
– volume: 77
  start-page: 755
  year: 2012
  end-page: 763
  article-title: Serum testosterone, dihydrotestosterone and estradiol concentrations in older men self‐reporting very good health: the healthy man study
  publication-title: Clin Endocrinol (Oxf)
– volume: 76
  start-page: 665
  year: 2012
  end-page: 673
  article-title: Total and free testosterone concentrations are strongly influenced by age and central obesity in men with type 1 and type 2 diabetes but correlate weakly with symptoms of androgen deficiency and diabetes‐related quality of life
  publication-title: Clin Endocrinol (Oxf)
– volume: 31
  start-page: 1207
  year: 2008
  end-page: 1213
  article-title: Sex hormone‐binding globulin and testosterone in individuals with childhood diabetes
  publication-title: Diabetes Care
– volume: 180
  start-page: 529
  year: 2004
  end-page: 535
  article-title: Androgen deficiency and replacement therapy in men
  publication-title: Med J Aust
– volume: 31
  start-page: 2013
  year: 2008
  end-page: 2017
  article-title: Testosterone concentration in young patients with diabetes
  publication-title: Diabetes Care
– volume: 30
  start-page: 726
  year: 2009
  end-page: 733
  article-title: Fifty‐two‐week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone
  publication-title: J Androl
– volume: 30
  start-page: 726
  year: 2009
  ident: 10.1111/j.2047-2927.2013.00124.x-BIB0021|andr124-cit-0021
  article-title: Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone
  publication-title: J Androl
  doi: 10.2164/jandrol.108.007005
  contributor:
    fullname: Heufelder
– volume: 96
  start-page: 3007
  year: 2011
  ident: 10.1111/j.2047-2927.2013.00124.x-BIB0002|andr124-cit-0002
  article-title: Clinical review: endogenous testosterone and mortality in men: a systematic review and meta-analysis
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2011-1137
  contributor:
    fullname: Araujo
– volume: 40
  start-page: 655
  year: 2011b
  ident: 10.1111/j.2047-2927.2013.00124.x-BIB0015|andr124-cit-0015
  article-title: Management of side effects of androgen deprivation therapy
  publication-title: Endocrinol Metab Clin North Am
  doi: 10.1016/j.ecl.2011.05.004
  contributor:
    fullname: Grossmann
– volume: 31
  start-page: 1207
  year: 2008
  ident: 10.1111/j.2047-2927.2013.00124.x-BIB0010|andr124-cit-0010
  article-title: Sex hormone-binding globulin and testosterone in individuals with childhood diabetes
  publication-title: Diabetes Care
  doi: 10.2337/dc07-2169
  contributor:
    fullname: Danielson
– volume: 74
  start-page: 377
  year: 2011
  ident: 10.1111/j.2047-2927.2013.00124.x-BIB0019|andr124-cit-0019
  article-title: Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy
  publication-title: Clin Endocrinol (Oxf)
  doi: 10.1111/j.1365-2265.2010.03942.x
  contributor:
    fullname: Hamilton
– volume: 93
  start-page: 2737
  year: 2008
  ident: 10.1111/j.2047-2927.2013.00124.x-BIB0032|andr124-cit-0032
  article-title: Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2007-1972
  contributor:
    fullname: Wu
– volume: 97
  start-page: 1508
  year: 2012
  ident: 10.1111/j.2047-2927.2013.00124.x-BIB0028|andr124-cit-0028
  article-title: Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS)
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2011-2513
  contributor:
    fullname: Tajar
– volume: 92
  start-page: 549
  year: 2007
  ident: 10.1111/j.2047-2927.2013.00124.x-BIB0029|andr124-cit-0029
  article-title: The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2006-1859
  contributor:
    fullname: Travison
– volume: 31
  start-page: 2013
  year: 2008
  ident: 10.1111/j.2047-2927.2013.00124.x-BIB0007|andr124-cit-0007
  article-title: Testosterone concentration in young patients with diabetes
  publication-title: Diabetes Care
  doi: 10.2337/dc08-0851
  contributor:
    fullname: Chandel
– volume: 78
  start-page: 321
  year: 2013
  ident: 10.1111/j.2047-2927.2013.00124.x-BIB0031|andr124-cit-0031
  article-title: Sex hormone binding globulin and insulin resistance
  publication-title: Clin Endocrinol (Oxf)
  doi: 10.1111/cen.12086
  contributor:
    fullname: Wallace
– volume: 361
  start-page: 1152
  year: 2009
  ident: 10.1111/j.2047-2927.2013.00124.x-BIB0013|andr124-cit-0013
  article-title: Sex hormone-binding globulin and risk of type 2 diabetes in women and men
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0804381
  contributor:
    fullname: Ding
– volume: 30
  start-page: 911
  year: 2007
  ident: 10.1111/j.2047-2927.2013.00124.x-BIB0023|andr124-cit-0023
  article-title: Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity
  publication-title: Diabetes Care
  doi: 10.2337/dc06-1426
  contributor:
    fullname: Kapoor
– volume: 295
  start-page: 1288
  year: 2006
  ident: 10.1111/j.2047-2927.2013.00124.x-BIB0012|andr124-cit-0012
  article-title: Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis
  publication-title: JAMA
  doi: 10.1001/jama.295.11.1288
  contributor:
    fullname: Ding
– volume: 26
  start-page: 1812
  year: 2003
  ident: 10.1111/j.2047-2927.2013.00124.x-BIB0009|andr124-cit-0009
  article-title: Steroids in adult men with type 1 diabetes: a tendency to hypogonadism
  publication-title: Diabetes Care
  doi: 10.2337/diacare.26.6.1812
  contributor:
    fullname: Dam
– volume: 2
  start-page: 146
  year: 2006
  ident: 10.1111/j.2047-2927.2013.00124.x-BIB0003|andr124-cit-0003
  article-title: Drug insight: testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging
  publication-title: Nat Clin Pract Endocrinol Metab
  doi: 10.1038/ncpendmet0120
  contributor:
    fullname: Bhasin
– volume: 77
  start-page: 755
  year: 2012
  ident: 10.1111/j.2047-2927.2013.00124.x-BIB0026|andr124-cit-0026
  article-title: Serum testosterone, dihydrotestosterone and estradiol concentrations in older men self-reporting very good health: the healthy man study
  publication-title: Clin Endocrinol (Oxf)
  doi: 10.1111/j.1365-2265.2012.04432.x
  contributor:
    fullname: Sartorius
– volume: 89
  start-page: 5462
  year: 2004
  ident: 10.1111/j.2047-2927.2013.00124.x-BIB0011|andr124-cit-0011
  article-title: Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2004-0804
  contributor:
    fullname: Dhindsa
– volume: 96
  start-page: 2341
  year: 2011c
  ident: 10.1111/j.2047-2927.2013.00124.x-BIB0014|andr124-cit-0014
  article-title: Low testosterone in men with type 2 diabetes: significance and treatment
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2011-0118
  contributor:
    fullname: Grossmann
– volume: 8
  start-page: 131
  year: 2012
  ident: 10.1111/j.2047-2927.2013.00124.x-BIB0025|andr124-cit-0025
  article-title: Testosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review
  publication-title: Curr Diabetes Rev
  doi: 10.2174/157339912799424573
  contributor:
    fullname: Saad
– volume: 168
  start-page: 445
  year: 2013
  ident: 10.1111/j.2047-2927.2013.00124.x-BIB0006|andr124-cit-0006
  article-title: Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study
  publication-title: Eur J Endocrinol
  doi: 10.1530/EJE-12-0890
  contributor:
    fullname: Camacho
– volume: 90
  start-page: 5928
  year: 2005
  ident: 10.1111/j.2047-2927.2013.00124.x-BIB0027|andr124-cit-0027
  article-title: Reproductive hormone reference intervals for healthy fertile young men: evaluation of automated platform assays
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2005-0962
  contributor:
    fullname: Sikaris
– volume: 17
  start-page: 247
  year: 2010
  ident: 10.1111/j.2047-2927.2013.00124.x-BIB0017|andr124-cit-0017
  article-title: Testosterone and type 2 diabetes
  publication-title: Curr Opin Endocrinol Diabetes Obes
  doi: 10.1097/MED.0b013e32833919cf
  contributor:
    fullname: Grossmann
– volume: 194
  start-page: 301
  year: 2011a
  ident: 10.1111/j.2047-2927.2013.00124.x-BIB0018|andr124-cit-0018
  article-title: Bone and metabolic health in patients with non-metastatic prostate cancer who are receiving androgen deprivation therapy
  publication-title: Med J Aust
  doi: 10.5694/j.1326-5377.2011.tb02979.x
  contributor:
    fullname: Grossmann
– volume: 75
  start-page: 772
  year: 2010
  ident: 10.1111/j.2047-2927.2013.00124.x-BIB0024|andr124-cit-0024
  article-title: Association between testosterone, estradiol and sex hormone binding globulin levels in men with type 1 diabetes with nephropathy
  publication-title: Steroids
  doi: 10.1016/j.steroids.2010.01.011
  contributor:
    fullname: Maric
– volume: 167
  start-page: 531
  year: 2012
  ident: 10.1111/j.2047-2927.2013.00124.x-BIB0022|andr124-cit-0022
  article-title: Body compositional and cardiometabolic effects of testosterone therapy in obese men with severe obstructive sleep apnoea: a randomised placebo-controlled trial
  publication-title: Eur J Endocrinol
  doi: 10.1530/EJE-12-0525
  contributor:
    fullname: Hoyos
– volume: 17
  start-page: 224
  year: 2010
  ident: 10.1111/j.2047-2927.2013.00124.x-BIB0001|andr124-cit-0001
  article-title: Androgens and obesity
  publication-title: Curr Opin Endocrinol Diabetes Obes
  doi: 10.1097/MED.0b013e3283398ee2
  contributor:
    fullname: Allan
– volume: 95
  start-page: 2536
  year: 2010
  ident: 10.1111/j.2047-2927.2013.00124.x-BIB0004|andr124-cit-0004
  article-title: Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2009-2354
  contributor:
    fullname: Bhasin
– volume: 76
  start-page: 665
  year: 2012
  ident: 10.1111/j.2047-2927.2013.00124.x-BIB0005|andr124-cit-0005
  article-title: Total and free testosterone concentrations are strongly influenced by age and central obesity in men with type 1 and type 2 diabetes but correlate weakly with symptoms of androgen deficiency and diabetes-related quality of life
  publication-title: Clin Endocrinol (Oxf)
  doi: 10.1111/j.1365-2265.2011.04196.x
  contributor:
    fullname: Biswas
– volume: 93
  start-page: 1834
  year: 2008
  ident: 10.1111/j.2047-2927.2013.00124.x-BIB0016|andr124-cit-0016
  article-title: Low testosterone levels are common and associated with insulin resistance in men with diabetes
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2007-2177
  contributor:
    fullname: Grossmann
– volume: 180
  start-page: 529
  year: 2004
  ident: 10.1111/j.2047-2927.2013.00124.x-BIB0020|andr124-cit-0020
  article-title: Androgen deficiency and replacement therapy in men
  publication-title: Med J Aust
  doi: 10.5694/j.1326-5377.2004.tb06060.x
  contributor:
    fullname: Handelsman
– volume: 34
  start-page: 528
  year: 2010
  ident: 10.1111/j.2047-2927.2013.00124.x-BIB0008|andr124-cit-0008
  article-title: Type 2 diabetes mellitus and testosterone: a meta-analysis study
  publication-title: Int J Androl
  doi: 10.1111/j.1365-2605.2010.01117.x
  contributor:
    fullname: Corona
– volume: 5
  start-page: 113
  year: 2009
  ident: 10.1111/j.2047-2927.2013.00124.x-BIB0033|andr124-cit-0033
  article-title: Testosterone and ill-health in aging men
  publication-title: Nat Clin Pract Endocrinol Metab
  doi: 10.1038/ncpendmet1050
  contributor:
    fullname: Yeap
– volume: 84
  start-page: 3666
  year: 1999
  ident: 10.1111/j.2047-2927.2013.00124.x-BIB0030|andr124-cit-0030
  article-title: A critical evaluation of simple methods for the estimation of free testosterone in serum
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.84.10.3666
  contributor:
    fullname: Vermeulen
SSID ssj0000800802
Score 2.131624
Snippet Summary Although men with type 2 diabetes (T2D) frequently have lowered testosterone levels, it is not well established whether this is ascribable to the...
Although men with type 2 diabetes (T2D) frequently have lowered testosterone levels, it is not well established whether this is ascribable to the diabetic...
Summary Although men with type 2 diabetes (T2D) frequently have lowered testosterone levels, it is not well established whether this is ascribable to the...
SourceID proquest
crossref
pubmed
pascalfrancis
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 906
SubjectTerms Adult
Age
Aged
ageing
Androgens
Biological and medical sciences
Body Mass Index
Cross-Sectional Studies
Diabetes
Diabetes Mellitus, Type 1 - blood
Diabetes Mellitus, Type 1 - complications
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - complications
Diabetes. Impaired glucose tolerance
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Etiopathogenesis. Screening. Investigations. Target tissue resistance
Fundamental and applied biological sciences. Psychology
Gynecology. Andrology. Obstetrics
Humans
Male
Male genital diseases
Mammalian male genital system
Medical sciences
Men
Metabolic diseases
Middle age
Middle Aged
Obesity
Obesity - complications
Obesity - epidemiology
Prevalence
Sex Hormone-Binding Globulin - analysis
Testosterone
Testosterone - blood
Vertebrates: reproduction
Victoria - epidemiology
Title Obesity and age as dominant correlates of low testosterone in men irrespective of diabetes status
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.2047-2927.2013.00124.x
https://www.ncbi.nlm.nih.gov/pubmed/24115523
https://www.proquest.com/docview/1638220971
https://search.proquest.com/docview/1447108641
Volume 1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dS-QwEB_UJ-Hw1D29nrrkQHzrYZN-5XFxV7w7WORU8C2k-QBBW7m6nP73N5N2Vwo-HHIvpbSTNJ1kkt8k8wFwjJp_bnwm4kIWp3TMmMRl4n1s8tzJKpWFkOTvfHFVzG_L6YzC5PxY-sJ08SFWG24kGWG-JgHXVTsQch6iDEhekIUWBSrFteob4UlUGoI3h7hcbbcQMCqDBWJfKpEDu5636xosVh8edYt8813Ci7cQ6RDghhXq_OP__Ldt2OpxKpt0A2sH1ly9C6NJjTr6wws7YcFyNGzJj0D32QWYri3D-Ynpltmms7FhhtJ_3BOiZY1n980f9kTJbCg-Q1M7dlezB1ezO8oR0jt9Et1yS5iRw9Oi_QQ357Prs4u4T90QmxQBZWxNrrmV1kgrvTg1hUTYY8vCcI0A1GrBfWUyYUxWZc4L6yvtnC6RVLsKVTaxBxs1tuIzMG6yXFfGI4lOdcnx87aUufeoXFsjfATJso_UYxehQ71qNsRHRXxUxEcV-KieIxgPOnNVkI5h07yUERwue1f1Qt0qgq6cU9CtCL6uXqM40hmLrl2zQJoUV3tUE1Ok2e9GxWvlaUIB70QEeej8f26umsynv_Duy3sLHsAmPe58KA9h4-n3wh3BemsX4yAmeJ1-__kXz3kRCg
link.rule.ids 315,782,786,1408,27935,27936,46066,46490
linkProvider Wiley-Blackwell
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9UwFD_ofFAQv-a0bs4I4ltlTdK0ebzsgyubF9EJvoU0HzDY2mF30f33OyftvaOwBxHfCj1J05Oc5HdOzgfAB9T8lYulyCtd7dE1Y5HXRYy5UyroRupKaIp3nn-vFj_rg0NKk3O8ioUZ8kOsDW4kGWm_JgEng_REynlKM6B5RS5alKkUD6tPCCgfSCU11XEQ4uva4ELQqE4-iGOzQk88e-7ubHJcPb60PXIuDiUv7sKkU4ibzqijp__1757BkxGqstmwtp7DvdC-gM1Zi2r6xTX7yJLzaLLKb4IdCwww23qGWxSzPfPd4GbDHFUAOSdQy7rIzrvf7Irq2VCKhq4N7KxlF6FlZ1QmZIz7JLqVVZhRzNOyfwk_jg5P9-f5WL0hdxIxZe6dstxr77TXUey5SiPy8XXluEUM6q3gsXGlcK5syhCFj40NwdZIakODWpvYgo0WR_EaGHelso2LSGKlrTl-3tdaxYj6tXciZlCsJslcDkk6zK1yQ3w0xEdDfDSJj-ZPBruT2Vw3pJtYqWqdwc5qes0o170h9Mo55d3K4P36NUokXbPYNnRLpJF44KOmKJHm1bAsbjuXBeW8ExmoNPt_PVwzWxx8w6c3_9rwHTycn345MSefF8fb8IhIhpDKHdi4-rUMb-F-75e7SWZuAIoCFDI
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3rSxwxEB9aC6VQtGqtq1YjlH7b4ib7ysfD87APDukD-i1k8wBBdw_XQ_3vncnunSz4QcRvCzvJZieZ5DeTeQB8Qc0_Nz4TcSGLI7pmTOIy8T42ee5klcpCSIp3Pv1TTP-X4xNKk_NjEQvT5YdYGtxIMsJ-TQI-s34g5DxkGZC8IA8tSlSKZ9U3xJNvUkLlFM4hzpb2FkJGZXBB7JslcuDY83hng9Pq_Uy3yDjfVbx4DJIOEW44oiZrL_lzH2C1B6ps1K2sdXjl6g3YHNWopF_esa8suI4Gm_wm6L68ANO1ZbhBMd0y23RONsxQ_Y8LgrSs8eyiuWHXVM2GEjQ0tWPnNbt0NTunIiF91CfRLWzCjCKe5u1H-Dc5-Xt8Gve1G2KTIqKMrck1t9IaaaUXR6aQiHtsWRiuEYFaLbivTCaMyarMeWF9pZ3TJZJqV6HOJrZgpcZRbAPjJst1ZTyS6FSXHD9vS5l7j9q1NcJHkCzmSM26FB3qQbUhPirioyI-qsBHdRvB_mAylw3pHjbNSxnB3mJ2VS_VrSLsyjll3YrgcPka5ZEuWXTtmjnSpHjco56YIs2nblU8dJ4mlPFORJCHyX_ycNVoOv6NTzvPbXgAb8_GE_Xr-_TnLrwjii6ecg9Wrq_m7jO8bu18P0jMPS20EuE
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Obesity+and+age+as+dominant+correlates+of+low+testosterone+in+men+irrespective+of+diabetes+status&rft.jtitle=Andrology+%28Oxford%29&rft.au=Ng+Tang+Fui%2C+M.&rft.au=Hoermann%2C+R.&rft.au=Cheung%2C+A.+S.&rft.au=Gianatti%2C+E.+J.&rft.date=2013-11-01&rft.issn=2047-2919&rft.eissn=2047-2927&rft.volume=1&rft.issue=6&rft.spage=906&rft.epage=912&rft_id=info:doi/10.1111%2Fj.2047-2927.2013.00124.x&rft.externalDBID=10.1111%252Fj.2047-2927.2013.00124.x&rft.externalDocID=ANDR124
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2047-2919&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2047-2919&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2047-2919&client=summon